Biotech Essentials: The Science, Business, and Financing of Therapeutics

Bridging the gap between laboratory science and commercial success is the ultimate challenge in the biotechnology industry. Navigating this complex landscape requires a solid grasp of both molecular biology and the financial strategies that fund life-saving innovations. By taking this course, you will gain a comprehensive understanding of the biotechnology ecosystem. You will learn how therapeutic discoveries transition from academic research into clinical trials, and eventually to the market, while studying the modern business and investment models that make this journey possible. What you will learn: Understand the foundational biology behind modern therapeutics, including gene editing, mRNA platforms, and monoclonal antibodies; Analyze the drug discovery and development pipeline, from preclinical target validation to clinical trial phases and regulatory approval; Evaluate biotechnology business models, intellectual property strategies, and licensing agreements; Explore modern financing structures, including venture capital, public markets, and strategic pharmaceutical partnerships; Examine the role of artificial intelligence and computational biology in accelerating drug discovery and reducing development costs. The course starts with foundational definitions of biotechnology, establishing key terminology and scientific principles. From there, you will progress through the regulatory landscape, intellectual property protection, and case studies of biotech financing and commercialization strategies. This course is designed specifically for beginners and requires no prior background in molecular biology or corporate finance. It is ideal for aspiring biotech entrepreneurs, investors, scientists looking to understand the business side, and business professionals entering the life sciences sector. Start reading today to master the essential forces driving the future of medicine.